Risks and benefits of zolpidem use in Taiwan: a narrative review
Tóm tắt
Zolpidem is a non-benzodiazepine hypnotic drug commonly used for the treatment of insomnia. However, to date, extensive evidence has shown that zolpidem use is a factor associated with certain clinical conditions, not that it treats these conditions. The aim of this review is to summarize current published articles on the risks and benefits of zolpidem use.
Tài liệu tham khảo
Su TP, Chen TJ, Hwang SJ, Chou LF, Fan AP, Chen YC. Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000. Zhonghua Yi Xue Za Zhi Taipei 2002; 65: 378–91.
Hsiao F-Y, Hsieh P-H, Gau C-S. Ten-year trend in prescriptions of z-hypnotics among the elderly: A nationwide, cross-sectional study in Taiwan. Journal of Clinical Gerontology and Geriatrics 2013; 4: 37–41.
Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B. The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure. Physiol Behav 1987; 41: 235–40.
Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, et al. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther 1998; 64: 553–61.
Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, et al. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 1986; 237: 649–58.
Langtry HD, Benfield P. Zolpidem: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 291–313.
Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem–an update. J Psychopharmacol 1999; 13: 81–93.
Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebocontrolled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994; 55: 192–9.
Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993; 12: 814–28.
Dang A, Garg A, Rataboli PV. Role of zolpidem in the management of insomnia. CNS Neurosci Ther 2011; 17: 387–97.
Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003; 26: 261–82.
Huang WS, Tsai CH, Lin CC, Muo CH, Sung FC, Chang YJ, et al. Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study. J Clin Psychiatry 2013; 74: e433–8.
Huang HC, Tsai CH, Muo CH, Lin KH, Lu MK, Sung FC, et al. Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study. J Clin Psychiatry 2015; 76: e104–10.
Harnod T, Wang YC, Sung FC, Kao CH. Association of zolpidem use and subsequent increased risk of epilepsy: a population-based, case-control study. J Clin Psychiatry 2014; 75: e1127–32.
Harnod T, Li YF, Lin CL, Chang SN, Sung FC, Kao CH. Higherdose uses of zolpidem will increase the subsequent risk of developing benign brain tumors. J Neuropsychiatry Clin Neurosci 2015; 27: e107–11.
Shih HI, Lin CC, Tu YF, Chang CM, Hsu HC, Chi CH, et al. An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine 2015; 94: 0000000000000809.
Kao CH, Sun LM, Liang JA, Chang SN, Sung FC, Muo CH. Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin Proc 2012; 87: 430–6.
Huang CY, Chou FH, Huang YS, Yang CJ, Su YC, Juang SY, et al. The association between zolpidem and infection in patients with sleep disturbance. J Psychiatr Res 2014; 54: 116–20.
Lai SW, Lin CL, Liao KF. Increased relative risk of acute pancreatitis in zolpidem users. Psychopharmacology 2015; 232: 2043–8.
Liao KF, Lin CL, Lai SW, Chen WC. Zolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess: A Case-Control Study in Taiwan. Medicine 2015; 94: 0000000000001302.
Yang YH, Lai JN, Lee CH, Wang JD, Chen PC. Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study. J Epidemiol 2011; 21: 37–43.
Lai MM, Lin CC, Liu CS, Li TC, Kao CH. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc 2014; 89: 589–94.
Lin FY, Chen PC, Liao CH, Hsieh YW, Sung FC. Retrospective population cohort study on hip fracture risk associated with zolpidem medication. Sleep 2014; 37: 673–9.
Lu TH, Lee YY, Lee HC, Lin YM. Doctor Shopping Behavior for Zolpidem Among Insomnia Patients in Taiwan: A Nationwide Population-Based Study. Sleep 2015; 38: 1039–44.
Wang LH, Lin HC, Lin CC, Chen YH. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther 2010; 88: 369–74.
Ho YH, Chang YC, Huang WC, Chen HY, Lin CC, Sung FC. Association between zolpidem use and glaucoma risk: a Taiwanese population-based case-control study. J Epidemiol 2015; 25: 15–9.